Are you positioning patients correctly?

In this post we discuss a case study detailing the importance of properly positioning and land marking the patient when performing a NeuroQuant® volumetric analysis.

glabellarWhen positioning a patient on the MRI table, land marking the X, Y and Z coordinates in the glabellar region is critical (see image). Land marking the patient in this region of the head, specifically the area between the eyebrows and above the nose, allows the center of the brain to align with the isocenter of the magnetic field. Magnetic field inhomogeneties are at their smallest magnitudes in isocenter. Therefore, positioning the head away from the isocenter in the + or – direction will cause greater distortion introduced by gradient nonlinearity.

If a sequence is acquired and uploaded to NeuroQuant with any of the X, Y or Z coordinates outside +/-100mm, automated volumetric analysis cannot be performed. An error message will be returned to the queue monitor and/or PACS. Below is an example of the NeuroQuant error message that would be generated in this case.

Cortechs.ai | Are you positioning patients correctly?

Automated volumetric analysis is not possible in these instances. If NeuroQuant returns such an error message, re-scanning the patient with the scan origin centered appropriately is advisable.

Important note: If your patient is having an MRI performed on a body part other than the brain (i.e. cervical, thoracic, lumbar spine) it is very important to re-establish the glabellar region of the head as isocenter prior to acquiring the NeuroQuant volumetric scan.

Interested in learning more about how to ensure accurate NeuroQuant output results?

  • Explore the importance of using a 3D T1 sagittal MRI sequences for NeuroQuant analysis. You can read that blog post here.
  • Review how to ensure accurate NeuroQuant processing results. You can read that blog post here.
  • Understand why contrast agents are not used to achieve quality segmentation with NeuroQuant. You can read that blog post here.
  • Examine why good alignment to atlas is necessary. You can read that blog post here.

Additionally, more information about using and processing NeuroQuant can be found here.

References:

  1. Caramanos Z. et al. Gradient distortions in MRI: characterizing and correcting for their effects on SIENNA-generated measure of brain volume change. Neuroimage, 2010, Jan15:49(2):1601-11.
  1. Velthuizen R. et al. Review and evaluation of MRI nonuniformity for brain tumor response measurements. Med. phys. 25, 1655(1998).

More Resources

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression
Scroll to Top